InvestorsHub Logo
Followers 38
Posts 5020
Boards Moderated 1
Alias Born 04/25/2010

Re: Chrism0000 post# 216084

Friday, 02/21/2020 11:14:02 AM

Friday, February 21, 2020 11:14:02 AM

Post# of 330175

Lets say everything goes BIEL way, they start selling and getting deals, where would the price end up, lets say in the next six months to a year, would they have to do a RS in the end?


Well, clearly huge news now has little immediate (and no long term) impact on the PPS. If full body FDA approval spiked to only .0015, and that being an intra-day only high point, and that with only half a billion shares traded, AND now the PPS is back to trips...... Certainly provides a clear picture of just how bad a position this company is in relative to significant increases in the PPS.

I think deals are taking longer that anticipated based on the latest shareholder update. CE mark still an issue, and remains so until possibly May. IF (or when ) deals are signed, it's doubtful sales will be immediate, and then profits will follow sometime thereafter. Then, of course, there's the share structure.....

Very risky to make predictions - after all, we have been reading predictions about how 'BIEL gets to a penny' for five years now, and never gotten closer than half that - completely erodes credibility when you see that..... However, I don't see as much as a half cent within six months, and I never see a penny until there are significant revenues, predictable profits, AND a change in share structure. If no large deals within two months (I am not talking things the the now never discussed HUGE VA approval that has generated bumpkus), OR no decent revenue increases by June, you can write off 2020 and start the '2021 is the year of BIEL' mantra.....